Global Emphysema Treatment Market Report By Diseases (COPD, Asthma), By Medication Class (Combination Products, Leukotriene Antagonists (LTA), Inhaled Corticosteroids (ICS), Anticholinergics, Short Acting Beta Agonists(SABA), Long Acting Beta Agonists (LABA), Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213520
October 2020
Report Formats:

The global demand for Emphysema Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Emphysema is a lung disease that involves reduction in the surface area of the lungs which in turn reduces the amount of oxygen reaching the bloodstream. Emphysema and chronic bronchitis are together known as Chronic Obstructive Pulmonary Disease (COPD). The patients who suffer from emphysema also have chronic bronchitis. The major causes of emphysema are exposure to chemical fumes, air pollutants, dust, and smoking. The state can be diagnosed through various tests such as lung function tests and imaging tests that include chest X-ray and CT scan.
 
Market Dynamics
 
The rising number of COPD and the asthmatic population worldwide coupled with FDA consent for the novel products and its wide adoption among the patient are the major factors driving the emphysema treatment market over the forecast period. Moreover, the high availability of diagnostic services for respiratory illness and rising government initiatives to control COPD and asthma are highly contributing to the global emphysema treatment market's growth. The technological advancement in the treatment of asthma and COPD and rising pipeline products holds immense potential for the growth of the global emphysema treatment market. Furthermore, increasing research and development in developing effective drugs with growing initiatives implemented by the non-government and government associations for creating health awareness are expected to create a lucrative opportunity for the key players in the coming years.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of emphysema treatment.
 
Market Segmentation
 
The entire emphysema treatment market has been sub-categorized into diseases and medication class. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Diseases

  • COPD
  • Asthma
 
By Medication Class
  • Combination Products
    • Seretide/Advair
    • Symbicort
    • Relvar/BreEllipta
    • Flutiform
    • Dulera
    • Others
  • Leukotriene Antagonists (LTA)
    • Singulair
    • Others
  • Inhaled Corticosteroids (ICS)
    • Qvar
    • Pulmicort
    • Aerospan
    • Flovent
    • Others
  • Anticholinergics
    • Spiriva
    • Others
  • Short Acting Beta Agonists(SABA)
    • ProAir
    • Ventolin
    • Others
  • Long Acting Beta Agonists (LABA)
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for emphysema treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Emphysema Treatment Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the emphysema treatment market include Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc., Bioxyne Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Emphysema Treatment Market
       2.2. Global Emphysema Treatment Market Snapshot
 
3 . EMPHYSEMA TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Emphysema Treatment Market
       3.3. Market Restraints of Emphysema Treatment Market
       3.4. Opportunities of Emphysema Treatment Market
       3.5. Trends of Emphysema Treatment Market
       3.6. Porter’s Five Force Analysis of Emphysema Treatment Market
       3.7. Emphysema Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Diseases
           3.7.2 Market Attractive Analysis by Medication Class
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Emphysema Treatment Value Chain Analysis
       4.2. Emphysema Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Emphysema Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Emphysema Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Emphysema Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Emphysema Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Emphysema Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Emphysema Treatment Market
 
6 . GLOBAL EMPHYSEMA TREATMENT MARKET ANALYSIS BY DISEASES
       6.1 Overview by Diseases
       6.2 Historical Data 2015-2018
       6.3 Global Emphysema Treatment Market Analysis by Diseases
       6.4 Market Analysis of COPD by Regions
       6.6 Market Analysis of Asthma by Regions
 
7 . GLOBAL EMPHYSEMA TREATMENT MARKET ANALYSIS BY MEDICATION CLASS
       7.1 Overview by Medication Class
       7.2 Historical Data 2015-2018
       7.3 Global Emphysema Treatment Market Analysis by Medication Class
       7.4 Market Analysis of Combination Products by Regions
       7.5 Market Analysis of Leukotriene Antagonists (LTA) by Regions
       7.6 Market Analysis of Inhaled Corticosteroids (ICS) by Regions
       7.7 Market Analysis of Anticholinergics by Regions
       7.8 Market Analysis of Short Acting Beta Agonists(SABA) by Regions
       7.9 Market Analysis of Long Acting Beta Agonists (LABA) by Regions
       7.10. Market Analysis of Others by Regions
 
8 . GLOBAL EMPHYSEMA TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America Emphysema Treatment Market Estimate By Market Segment
           8.3.3. North America Emphysema Treatment Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe Emphysema Treatment Market Estimate by Market Segment
           8.4.3. Europe Emphysema Treatment Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific Emphysema Treatment Market Estimate by Market Segment
           8.5.3. Asia Pacific Emphysema Treatment Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America Emphysema Treatment Market Estimate by Market Segment
           8.6.3. Latin America Emphysema Treatment Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa Emphysema Treatment Market Estimate by Market Segment
           8.7.3. Middle East & Africa Emphysema Treatment Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE EMPHYSEMA TREATMENT COMPANIES
       9.1. Emphysema Treatment Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF EMPHYSEMA TREATMENT INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Intrexon Corporation
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Pulmonx Inc.,
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Halozyme Therapeutics, Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Mariposa Health Limited
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. PneumRx
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Uptake Medical Corporation
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Icure Pharmaceuticals, Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Pfizer, Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. BTG International’s
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Olympus Corporation,
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Kamada Limited
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. Emphasys Medical, Inc.
           10.14.1. Company Overview
           10.14.2. Financials
           10.14.3. Products
           10.14.4. Recent Developments
       10.15. Bioxyne Limited
           10.15.1. Company Overview
           10.15.2. Financials
           10.15.3. Products
           10.15.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Emphysema Treatment Market Snapshot
  • Drivers of The Global Emphysema Treatment Market Impact Analysis
  • Restraints of The Global Emphysema Treatment Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Emphysema Treatment Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Emphysema Treatment Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Emphysema Treatment Market
  • Global Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Historic Data 2015-2018
  • Global Emphysema Treatment Market Analysis in COPD by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis in Asthma by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis by Medication Class ( USD MN)
  • Historic Data 2015-2018
  • Global Emphysema Treatment Market Analysis in Combination Products by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis in Leukotriene Antagonists (LTA) by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis in Inhaled Corticosteroids (ICS) by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis in Anticholinergics by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis in Short Acting Beta Agonists(SABA) by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis in Long Acting Beta Agonists (LABA) by Geography ( USD MN)
  • Global Emphysema Treatment Market Analysis in Others by Geography ( USD MN)
  • Global Emphysema Treatment Market by Geography ( USD MN)
  • Historic Data 2015-2018
  • North America Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • North America Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • North America Emphysema Treatment Market Estimate by Country ( USD MN)
  • United State Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • United State Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Canada Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Canada Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Mexico Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Mexico Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Europe Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Europe Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Europe Emphysema Treatment Market Estimate by Country ( USD MN)
  • United Kingdom Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • United Kingdom Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • France Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • France Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Germany Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Germany Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Italy Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Italy Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Russia Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Russia Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Spain Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Spain Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Rest of Europe Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Rest of Europe Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Asia Pacific Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Asia Pacific Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Asia Pacific Emphysema Treatment Market Estimate by Country ( USD MN)
  • China Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • China Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Japan Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Japan Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • India Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • India Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • South Korea Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • South Korea Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Australia Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Australia Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Rest of Asia Pacific Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Rest of Asia Pacific Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Latin America Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Latin America Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Latin America Emphysema Treatment Market Estimate by Country ( USD MN)
  • Brazil Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Brazil Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Argentina Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Argentina Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Peru Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Peru Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Chile Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Chile Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Rest of Latin America Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Rest of Latin America Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Middle East & Africa Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Middle East & Africa Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Middle East & Africa Emphysema Treatment Market Estimate by Country ( USD MN)
  • Saudi Arabia Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Saudi Arabia Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • UAE Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • UAE Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Israel Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Israel Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • South Africa Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • South Africa Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Rest of Middle East and Africa Emphysema Treatment Market Analysis by Diseases ( USD MN)
  • Rest of Middle East and Africa Emphysema Treatment Market Estimate by Medication Class ( USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Emphysema Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Emphysema Treatment Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Diseases
  • Market Attractiveness Analysis by Medication Class
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Emphysema Treatment Market Analysis by Diseases
  • Global Emphysema Treatment Market Analysis in COPD by Region
  • Global Emphysema Treatment Market Analysis in Asthma by Region
  • Global Emphysema Treatment Market Analysis by Medication Class
  • Global Emphysema Treatment Market Analysis in Combination Products by Region
  • Global Emphysema Treatment Market Analysis in Leukotriene Antagonists (LTA) by Region
  • Global Emphysema Treatment Market Analysis in Inhaled Corticosteroids (ICS) by Region
  • Global Emphysema Treatment Market Analysis in Anticholinergics by Region
  • Global Emphysema Treatment Market Analysis in Short Acting Beta Agonists(SABA) by Region
  • Global Emphysema Treatment Market Analysis in Long Acting Beta Agonists (LABA) by Region
  • Global Emphysema Treatment Market Analysis in Others by Region
  • Global Emphysema Treatment Market by Revenue
  • North America Emphysema Treatment Market by Revenue
  • Europe Emphysema Treatment Market by Revenue
  • Asia Pacific Emphysema Treatment Market by Revenue
  • Latin America Emphysema Treatment Market by Revenue
  • Middle East & Africa Emphysema Treatment Market by Revenue
  • Recent Development in Emphysema Treatment Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials